Treponema pallidum genetic diversity and its implications for targeted vaccine development: A cross-sectional study of early syphilis cases in Southwestern Colombia
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0307600 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von Juan C Salazar und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Connecticut School of Medicine, Farmington, CT, United States of America. Hauptthemen laut MEDLINE: Treponema pallidum, Syphilis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, FIC NIH HHS, Gates Foundation.
Abstract (Originalsprache)
Background
Venereal syphilis, caused by the spirochete Treponema pallidum subsp. pallidum ( TPA ), is surging worldwide, underscoring the need for a vaccine with global efficacy. Vaccine development requires an understanding of syphilis epidemiology and clinical presentation as well as genomic characterization of TPA strains circulating within at-risk populations. The aim of this study was to describe the clinical, demographic, and molecular features of early syphilis cases in Cali, Colombia. Methods and findings We conducted a cross-sectional study to identify individuals with early syphilis (ES) in Cali, Colombia through a city-wide network of public health centers, private sector HIV clinics and laboratory databases from public health institutions. Whole blood (WB), skin biopsies (SB), and genital and oral lesion swabs were obtained for measurement of treponemal burdens by polA quantitative polymerase chain reaction (qPCR) and for whole-genome sequencing (WGS). Among 1,966 individuals screened, 128 participants met enrollment criteria: 112 (87%) with secondary (SS), 15 (12%) with primary (PS) and one with early latent syphilis; 66/128 (52%) self-reported as heterosexual, while 48 (38%) were men who have sex with men (MSM). Genital ulcer swabs had the highest polA copy numbers (67 copies/μl) by qPCR with a positivity rate (PR) of 73%, while SS lesions had 42 polA copies/μl with PR of 62%. WB polA positivity was more frequent in SS than PS (42% vs 7%, respectively; p = 0.009). Isolation of TPA from WB by rabbit infectivity testing (RIT) was achieved in 5 (56%) of 9 ES WB samples tested. WGS from 33 Cali patient samples, along with 10 other genomic sequences from South America (9 from Peru, 1 from Argentina) used as comparators, confirmed that SS14 was the predominant clade, and that half of all samples had mutations associated with macrolide ( i . e ., azithromycin) resistance. Variability in the outer membrane protein (OMP) and vaccine candidate BamA (TP0326) was mapped onto the protein’s predicted structure from AlphaFold. Despite the presence of mutations in several extracellular loops (ECLs), ECL4, an immunodominant loop and proven opsonic target, was highly conserved in this group of Colombian and South American TPA isolates.
Conclusions
This study offers new insights into the sociodemographic and clinical features of venereal syphilis in a highly endemic area of Colombia and illustrates how genomic sequencing of regionally prevalent TPA strains can inform vaccine development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of Connecticut School of Medicine, Farmington, CT, United States of America.
- Department of Immunology, University of Connecticut School of Medicine, Farmington, CT, United States of America.
- Division of Infectious Diseases, Connecticut Children's, Hartford, CT, United States of America.
- Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM), Cali, Colombia.
- Universidad ICESI, Cali, Colombia.
- Division of Dermatology, School of Medicine, Universidad del Valle, Cali, Colombia.
ORCID-Profile: Juan C Salazar, Fabio Vargas-Cely, Jonny A García-Luna, Alvaro J Martínez-Valencia, Eduardo López-Medina
Förderung
- Wellcome Trust
- FIC NIH HHS
- Gates Foundation
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Bill and Melinda Gates Foundation
- Fogarty International Center
Zitieren
APA
Salazar, J. C., Vargas-Cely, F., García-Luna, J. A., Ramirez, L. G., Bettin, E. B., Romero-Rosas, N., Amórtegui, M. F., Silva, S., Oviedo, O., Vigil, J., La Vake, C. J., Galindo, X., Ramirez, J. D., Martínez-Valencia, A. J., Caimano, M. J., Hennelly, C. M., Aghakhanian, F., Moody, M. A., Seña, A. C., …, & Radolf, J. D. (2024). Treponema pallidum genetic diversity and its implications for targeted vaccine development: A cross-sectional study of early syphilis cases in Southwestern Colombia. PLOS ONE. https://doi.org/10.1371/journal.pone.0307600
Vancouver
Salazar JC, Vargas-Cely F, García-Luna JA, Ramirez LG, Bettin EB, Romero-Rosas N, et al. Treponema pallidum genetic diversity and its implications for targeted vaccine development: A cross-sectional study of early syphilis cases in Southwestern Colombia. PLOS ONE. 2024. doi:10.1371/journal.pone.0307600
BibTeX
@article{Salazar2024,
author = {Salazar, Juan C and Vargas-Cely, Fabio and García-Luna, Jonny A and Ramirez, Lady G and Bettin, Everton B and Romero-Rosas, Nelson and Amórtegui, María F and Silva, Sebastián and Oviedo, Oscar and Vigil, Julie and La Vake, Carson J and Galindo, Ximena and Ramirez, Jose D and Martínez-Valencia, Alvaro J and Caimano, Melissa J and Hennelly, Christopher M and Aghakhanian, Farhang and Moody, M Anthony and Seña, Arlene C and Parr, Jonathan B and Hawley, Kelly L and López-Medina, Eduardo and Radolf, Justin D},
title = {Treponema pallidum genetic diversity and its implications for targeted vaccine development: A cross-sectional study of early syphilis cases in Southwestern Colombia},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0307600}
}
EUVIMED